Tag:
Mersana Therapeutics
Latest Headlines
Latest Headlines
Mersana snaps up $270M cancer drug deal with Endo Pharma
Endo Pharmaceuticals ( $ENDP ) has tapped Mersana to create antibody-drug conjugates against an undisclosed cancer target.
Mersana, Teva ink $334M deal for preclinical cancer drug
Cambridge, MA-based Mersana Therapeutics has forged its first big licensing pact, inking a $334 million collaboration deal with Teva for a preclinical cancer drug program. Under the deal, Mersana
